Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
01/23/2001 | US6177283 Detecting components in sample; provide blotter and applying sample liquid, dry liquid on blotter, elute and count preferential component from dried sample |
01/23/2001 | US6177282 Immunoassay for detecting binding agents in sample; incubating sample with phosphatide binding agent, detect preferentially bound phosphatides |
01/23/2001 | US6177281 Device for the efficient and accurate detection and analysis of compounds in a sample |
01/23/2001 | US6177280 Ricin inhibitors and methods for use thereof |
01/23/2001 | US6177277 Cytometric process for analyzing cells and particles in a sample; providing a flow cytometer, activating fluid sample flowing through channel in cuvette and detecting fluorescent signal |
01/23/2001 | US6177276 Oxidation and measurement of phosphonates in aqueous solutions |
01/23/2001 | US6177270 Reaction-based selection for expression of and concentration of catalytic moieties |
01/23/2001 | US6177260 Simple, efficient method of analyzing thiol group containing proteins, glutathione, cysteine, flavonoids, and vitamin e by contacting in active and deactive state with oxidant resulting in change of absorbance spectra and comparing |
01/23/2001 | US6177259 Screening for inhibitors by incubating caspase, polyglutamine peptide, and candidate where reduction in complex formation indicates inhibitor; treatment of nervous system disorders such as huntington's disease |
01/23/2001 | US6177257 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
01/23/2001 | US6177255 Immunoassay method by contacting tumor tissue cytosol with antihormone receptor antibody to form complex, removing liquid, incubating complex with hormone or antihormone, contacting with enzyme labeled antibody, measuring color |
01/23/2001 | US6177253 Screening methods for the identification of anti-HIV compounds employing a cyclosporine-specific monoclonal antibody that cross-reacts with HIV-1 p24 |
01/23/2001 | US6177251 Separating mammalian nucleic acid from sample by removing particulate matter from sample in a lysis buffer, then separating out nucleic acids; buffer does not lyse bacterial cells; screening for mutation in gene indicative of cancer |
01/23/2001 | US6177250 Nucleic acid mediated electron transfer |
01/23/2001 | US6177248 Detecting expression of at least one gene down-stream from wt1 and comparing to wild type cells; a difference suggests mutation; diagnosis of cancer/tumor |
01/23/2001 | US6177247 Distinguishing different nucleic acid sequences produced using polymerase by incorporating different fluorescent energy transfer labels into each nucleic acid, separating, irradiating with light, and detecting emission; sequencing |
01/23/2001 | US6177245 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
01/23/2001 | US6177243 Nucleic acid sequence detection employing amplification probes |
01/23/2001 | US6177241 Use of peptides to improve specificity of an immunoassay for the detection of cytomegalovirus specific IgM antibody |
01/23/2001 | US6177106 Method for fractionating red blood cells and antibacterial materials for bacterial proliferation inhibitors produced thereby |
01/23/2001 | US6177088 Surface-functionalized, probe-containing nanospheres |
01/23/2001 | US6177081 Human and marmoset activating viruses |
01/23/2001 | US6177051 Dispenser, analyzer, detector |
01/23/2001 | US6177000 Biosensor operates by detecting or measuring the transport of ions across a lipid membrane |
01/23/2001 | US6176990 Micro-electrophoresis chip for moving and separating nucleic acids and other charged molecules |
01/23/2001 | US6176974 Method for determining electrokinetic properties of papermaking furnish |
01/23/2001 | US6176199 Method for localizing allantoic fluid of avian eggs |
01/23/2001 | US6176120 Methods of analyzing water soluble contaminants generated during microelectronic device manufacturing processes |
01/23/2001 | CA2296884C Targeted liposomes and methods for liposome-protein coupling |
01/23/2001 | CA2221178C Wholly microfabricated biosensors and process for the manufacture and use thereof |
01/23/2001 | CA2219640C Fluid testing and analysing device and method |
01/23/2001 | CA2122473C Nuclear matrix protein fluid assay |
01/23/2001 | CA2017369C Modified phosphoramidite process for the production or modified nucleic acids |
01/18/2001 | WO2001004828A1 Automated detection of objects in a biological sample |
01/18/2001 | WO2001004636A1 Mammalian cells expressing desaturases and elongases |
01/18/2001 | WO2001004635A1 Rapid test employing an adhesive slide |
01/18/2001 | WO2001004634A1 Antigen recovery and/or staining apparatus and method |
01/18/2001 | WO2001004633A2 Preparation of spheres for diagnostic tests |
01/18/2001 | WO2001004632A1 Oligosaccharide metabolites of glycosaminoglycans and their use in the diagnosis and treatment of complications of diabetes |
01/18/2001 | WO2001004631A1 A sensor comprising a hydrophilic matrix material |
01/18/2001 | WO2001004630A1 Measurement of analytes in whole blood |
01/18/2001 | WO2001004629A1 E4orf4 and pp2a polypeptides, modulators, and mimetics for selectively inducing cell death |
01/18/2001 | WO2001004628A1 Method for assaying compounds affecting cell division |
01/18/2001 | WO2001004627A1 Soil measuring instrument, soil measurement assisting device and method, recorded medium on which program is recorded, recorded medium on which data is recorded, application amount controller, application amount determining device, method for them, and farm working determination assisting system |
01/18/2001 | WO2001004626A1 An electrochemical method for enrichment of microorganism, a biosensor for analyzing organic substance and bod |
01/18/2001 | WO2001004623A1 Optical sensor for potassium ions |
01/18/2001 | WO2001004620A1 Improved method and device for counting inclusions in a liquid metal bath with ultrasounds |
01/18/2001 | WO2001004614A1 Electrochemical biosensor using silver silver chloride electrode and chromatography matrix |
01/18/2001 | WO2001004613A1 Microfabricated injector and capillary array assembly for high-resolution and high throughput separations |
01/18/2001 | WO2001004612A2 A method of determining the content of a component in a fluid sample and an apparatus therefor |
01/18/2001 | WO2001004607A1 Image data analysis of objects |
01/18/2001 | WO2001004361A2 Detection of hiv-1 by nucleic acid amplification |
01/18/2001 | WO2001004354A2 Use of ras inhibitors of inhibiting muscle atrophy |
01/18/2001 | WO2001004351A2 Genetic test for detecting a predisposition to a disease associated with abnormal vegf gene expression |
01/18/2001 | WO2001004350A1 Cell line comprising the promoter of cyclooxygenase-2 (cox-2) and a witness gene, and use thereof in the search of cox-2 transcriptional induction selective inhibitors |
01/18/2001 | WO2001004349A2 Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease |
01/18/2001 | WO2001004344A2 Induction of a th1-like response in vitro |
01/18/2001 | WO2001004343A2 A method for determining the prognosis of cancer patients by measuring levels of bag expression |
01/18/2001 | WO2001004326A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
01/18/2001 | WO2001004318A2 Myxoma virus genes for immune modulation |
01/18/2001 | WO2001004316A2 Antigenic meningococcal peptides |
01/18/2001 | WO2001004311A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/18/2001 | WO2001004309A1 T-CELL RECEPTOR η ALTERNATE READING FRAME PROTEIN, (TARP) AND USES THEREOF |
01/18/2001 | WO2001004308A1 Human lim domain proteins |
01/18/2001 | WO2001004306A1 Expression vectors and methods |
01/18/2001 | WO2001004305A2 Human proteins involved in detoxification |
01/18/2001 | WO2001004304A1 Human cytokine receptor |
01/18/2001 | WO2001004303A1 Compositions corresponding to a calcium transporter and methods of making and using same |
01/18/2001 | WO2001004298A1 Novel physiologically active substance, process for producing the same and use thereof |
01/18/2001 | WO2001004292A1 G-protein coupled receptor and dna sequences thereof |
01/18/2001 | WO2001004287A1 A method for preparing modified polypeptides |
01/18/2001 | WO2001004281A2 Dna coding for beta-tubulin and use thereof |
01/18/2001 | WO2001004265A2 C-terminal protein tagging |
01/18/2001 | WO2001004264A2 Atherosclerosis-associated genes |
01/18/2001 | WO2001004158A1 Method for determining dna double-stranded breaks |
01/18/2001 | WO2001004157A2 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
01/18/2001 | WO2001004151A2 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
01/18/2001 | WO2001004141A2 Seripancrin |
01/18/2001 | WO2001004133A1 Human eag2 |
01/18/2001 | WO2001004057A1 Method and apparatus for removing oil from water including monitoring of adsorbent saturation |
01/18/2001 | WO2001003841A1 System and self-moving device for the control of milling processes |
01/18/2001 | WO2001003743A1 Manipulation of tissue or organ type using the notch pathway |
01/18/2001 | WO2001003722A1 Cftr polypeptides, fragments thereof and methods of use to overcome biosynthetic misprocessing |
01/18/2001 | WO2001003721A1 Improved assays for detecting human immunodeficiency virus infection |
01/18/2001 | WO2001003720A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
01/18/2001 | WO2001003692A1 Compositions and methods for promoting nerve regeneration |
01/18/2001 | WO2001003582A1 Medical measuring device |
01/18/2001 | WO2001003573A2 Method of diagnosis of cardiac hypertrophy |
01/18/2001 | WO2000063415A8 Dna encoding the human vanilloid receptor vr1 |
01/18/2001 | WO2000063378A3 Zalpha13: a human secreted protein |
01/18/2001 | WO2000056864A3 Methods for altering substrate specificity of phosphoinositide-dependent-protein kinase 1 (pdk1) |
01/18/2001 | WO2000055180A3 Human lung cancer associated gene sequences and polypeptides |
01/18/2001 | WO2000049382A3 Bead dispensing system |
01/18/2001 | WO2000047723A3 Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same |
01/18/2001 | WO2000043782A3 Removal of prions from blood, plasma and other liquids |
01/18/2001 | WO2000032825A3 Development of anti-microbial agents based on bacteriophage genomics |
01/18/2001 | WO2000019210A3 Determining the mechanism of beta-amyloid peptide generation |
01/18/2001 | WO1999064620A3 Diagnostic assay requiring a small sample of biological fluid |
01/18/2001 | WO1999064049A9 Novel antibacterial agents |